These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38601916)

  • 1. Synaptic density patterns in early Alzheimer's disease assessed by independent component analysis.
    Fang XT; Raval NR; O'Dell RS; Naganawa M; Mecca AP; Chen MK; van Dyck CH; Carson RE
    Brain Commun; 2024; 6(2):fcae107. PubMed ID: 38601916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Principal component analysis of synaptic density measured with [
    O'Dell RS; Higgins-Chen A; Gupta D; Chen MK; Naganawa M; Toyonaga T; Lu Y; Ni G; Chupak A; Zhao W; Salardini E; Nabulsi NB; Huang Y; Arnsten AFT; Carson RE; van Dyck CH; Mecca AP
    Neuroimage Clin; 2023; 39():103457. PubMed ID: 37422964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease.
    Kreisl WC; Lyoo CH; McGwier M; Snow J; Jenko KJ; Kimura N; Corona W; Morse CL; Zoghbi SS; Pike VW; McMahon FJ; Turner RS; Innis RB;
    Brain; 2013 Jul; 136(Pt 7):2228-38. PubMed ID: 23775979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging.
    Chen MK; Mecca AP; Naganawa M; Finnema SJ; Toyonaga T; Lin SF; Najafzadeh S; Ropchan J; Lu Y; McDonald JW; Michalak HR; Nabulsi NB; Arnsten AFT; Huang Y; Carson RE; van Dyck CH
    JAMA Neurol; 2018 Oct; 75(10):1215-1224. PubMed ID: 30014145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the relationship between synaptic density and metabotropic glutamate receptors in early Alzheimer's disease: a multi-tracer PET study.
    Salardini E; O'Dell RS; Tchorz E; Nabulsi NB; Huang Y; Carson RE; van Dyck CH; Mecca AP
    bioRxiv; 2024 Sep; ():. PubMed ID: 39386453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Exposure-Response Modeling of Multiple Indicators of Alzheimer's Disease Progression.
    Polhamus DG; Dolton MJ; Rogers JA; Honigberg L; Jin JY; Quartino A
    J Prev Alzheimers Dis; 2023; 10(2):212-222. PubMed ID: 36946448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementia.
    Sabri O; Meyer PM; Gräf S; Hesse S; Wilke S; Becker GA; Rullmann M; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Tiepolt S; Fischer S; Deuther-Conrad W; Hegerl U; Barthel H; Schönknecht P; Brust P
    Brain; 2018 Jun; 141(6):1840-1854. PubMed ID: 29672680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perforant path synaptic loss correlates with cognitive impairment and Alzheimer's disease in the oldest-old.
    Robinson JL; Molina-Porcel L; Corrada MM; Raible K; Lee EB; Lee VM; Kawas CH; Trojanowski JQ
    Brain; 2014 Sep; 137(Pt 9):2578-87. PubMed ID: 25012223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition.
    Vemuri P; Weigand SD; Przybelski SA; Knopman DS; Smith GE; Trojanowski JQ; Shaw LM; Decarli CS; Carmichael O; Bernstein MA; Aisen PS; Weiner M; Petersen RC; Jack CR;
    Brain; 2011 May; 134(Pt 5):1479-92. PubMed ID: 21478184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of neurodegeneration using a multivariate early frame amyloid PET classifier.
    Matthews DC; Lukic AS; Andrews RD; Wernick MN; Strother SC; Schmidt ME;
    Alzheimers Dement (N Y); 2022; 8(1):e12325. PubMed ID: 35846158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau accumulation and its spatial progression across the Alzheimer's disease spectrum.
    St-Onge F; Chapleau M; Breitner JCS; Villeneuve S; Pichet Binette A
    Brain Commun; 2024; 6(1):fcae031. PubMed ID: 38410618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of entorhinal cortical tau deposition and hippocampal synaptic density in older individuals with normal cognition and early Alzheimer's disease.
    Mecca AP; Chen MK; O'Dell RS; Naganawa M; Toyonaga T; Godek TA; Harris JE; Bartlett HH; Zhao W; Banks ER; Ni GS; Rogers K; Gallezot JD; Ropchan J; Emery PR; Nabulsi NB; Vander Wyk BC; Arnsten AFT; Huang Y; Carson RE; van Dyck CH
    Neurobiol Aging; 2022 Mar; 111():44-53. PubMed ID: 34963063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo tau pathology is associated with synaptic loss and altered synaptic function.
    Coomans EM; Schoonhoven DN; Tuncel H; Verfaillie SCJ; Wolters EE; Boellaard R; Ossenkoppele R; den Braber A; Scheper W; Schober P; Sweeney SP; Ryan JM; Schuit RC; Windhorst AD; Barkhof F; Scheltens P; Golla SSV; Hillebrand A; Gouw AA; van Berckel BNM
    Alzheimers Res Ther; 2021 Feb; 13(1):35. PubMed ID: 33546722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting functional decline in aging and Alzheimer's disease with PET-based Braak staging.
    Macedo AC; Therriault J; Tissot C; Fernandez-Arias J; Ferreira PCL; Vitali P; Servaes S; Rahmouni N; Vermeiren M; Bezgin G; Lussier FZ; Stevenson J; Wang YT; Socualaya KQ; Kunach P; Nazneen T; Hosseini SA; Pallen V; Stevenson A; Ferrari-Souza JP; Bellaver B; Leffa DT; Ng KP; Zimmer ER; Pascoal TA; Gauthier S; Rosa-Neto P
    Brain Commun; 2024; 6(2):fcae043. PubMed ID: 38482373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance.
    Scarmeas N; Habeck CG; Zarahn E; Anderson KE; Park A; Hilton J; Pelton GH; Tabert MH; Honig LS; Moeller JR; Devanand DP; Stern Y
    Neuroimage; 2004 Sep; 23(1):35-45. PubMed ID: 15325350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative
    Zhao Q; Liu M; Ha L; Zhou Y;
    Front Neurol; 2019; 10():486. PubMed ID: 31156534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.